You are on page 1of 6

Original Report

Diagnostic Performance of a Sonographic Volume and Solid


Vascular Tissue Score (VSVTS) for Preoperative Risk Assessment
of Pediatric and Adolescent Adnexal Masses
s Roca MD 1,2, Ebtehaj D. Alshehri MD 1,2, Hanna R. Goldberg MD, MS 3,
Lara Farra
Afsaneh Amirabadi PhD 1, Sari Kives MD 4,5, Lisa Allen MD 4,5, Oscar M. Navarro MD 1,2,
Christopher Z. Lam MD 1,2,*
1
Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada
2
Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada
3
Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
4
Section of Gynecology, The Hospital for Sick Children, Toronto, Ontario, Canada
5
Department of Obstetrics and Gynecology, University of Toronto, Ontario, Canada

a b s t r a c t
Study Objective: To evaluate the diagnostic performance of a Volume and Solid Vascular Tissue Score (VSVTS) for preoperative risk
assessment of pediatric and adolescent adnexal masses.
Design: A retrospective cohort study comprised of all female individuals who presented with an adnexal mass that was managed surgically
between April 2011 and March 2016.
Setting: The Hospital for Sick Children (Toronto, Ontario, Canada).
Participants: Female individuals 1e18 years of age who presented to a large tertiary pediatric hospital with an adnexal mass that was
managed surgically.
Main Outcome Measures: Main outcome measures included diagnostic performance of the VSVTS for malignancy via sensitivity, specificity,
positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LRþ), negative likelihood ratio (LR), and
receiver operating characteristic area-under-the-curve (AUC) analysis.
Results: A total of 179 masses in 169 subjects were included. The malignancy rate was 10.6%. The AUC for the VSTVS was 0.919. A VSTVS cut-
off value of 4 achieved a sensitivity of 79% (95% CI 0.54-0.93), specificity of 88% (95% CI 0.82-0.93), PPV of 0.44 (95% CI 0.33-0.56), NPV of
0.97 (95% CI 0.94-0.99), LRþ of 6.77 (95% CI 4.18-10.97), and LR of 0.24 (95% CI 0.10-0.57).
Conclusions: A sonographic scoring system based on the volume and presence of solid vascular tissue improves PPV for preoperative risk
stratification of adnexal masses in the pediatric and adolescent population compared to existing ultrasound-only approaches. Further
prospective research is needed to determine how best to incorporate components of such scoring systems into clinical management
algorithms.
Key Words: Adnexal mass, Benign, Malignancy, Oophorectomy, Ovarian cystectomy, Preoperative procedure, Risk stratification,
Sonography

Introduction A previous retrospective study conducted at our insti-


tution showed that malignant masses can be preoperatively
The incidence of adnexal masses in girls and adolescents is identified using a threshold of greater than 8 cm in size and
approximately 2.6/100,000 girls per year.1 Up to 10-20% of presence of “complex” features by ultrasound. These criteria
surgically managed masses are malignant.2 Accurate preop- yielded a negative predictive value (NPV) of 100% but a
erative risk assessment is critical, as it affects the surgical positive predictive value (PPV) of only 37.1%.3 Therefore,
approach.3 For presumed benign masses that require inter- relying on such criteria alone would lead to a high propor-
vention, a conservative approach with laparoscopic cys- tion of undesirable oophorectomies for benign lesions.
tectomy is preferred. Malignancies, on the other hand, Multiple more-complicated risk assessment algorithms
usually require an open laparotomy with oophorectomy, have been studied in attempts to improve the preoperative
which has a consequent impact on patient fertility.2,3 None- PPV.2e10 Most recently, we attempted replication of the
theless, the optimal method for preoperative risk assessment Decision Tree System (DTS) proposed by Stankovic et al,4
in the pediatric and adolescent population remains elusive. which in their study demonstrated a preoperative NPV of
99% and PPV of 86%. The results of our replication attempt
None of the authors have any conflicts of interest or financial ties to disclose.
were less encouraging, as we achieved an NPV of 98% but a
The authors report no funding for this work. PPV of only 30% in our population.4
* Address correspondence to: Christopher Z. Lam, MD, Department of Diagnostic Concurrently, we hypothesized that a scoring system
Imaging, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario
M5G 1X8, Canada; Phone: (416) 823-2887; fax: (416) 813-8389
accounting for the vascularity of adnexal masses as has
E-mail address: Christopher.lam@sickkids.ca (C.Z. Lam). been introduced in adult algorithms, such as in the IOTA
1083-3188/$ - see front matter Ó 2020 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc.
https://doi.org/10.1016/j.jpag.2020.11.017

Downloaded for Anonymous User (n/a) at Jawaharlal Institute of Postgraduate Medical Education and Research from ClinicalKey.in by
Elsevier on June 07, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.
378 s Roca et al. / J Pediatr Adolesc Gynecol 34 (2021) 377e382
L. Farra

rules and O-RADS,11,12 might improve the PPV. These algo- Table 1
Volume and Solid Vascular Tissue Score (VSVTS)
rithms incorporate a subjective degree of vascularity in risk
assessment, whereas in our experience any solid vascular
Solid vascular tissue score*
tissue alone increases malignancy risk. The purpose of this 1. No solid vascular tissue
study was therefore to evaluate the diagnostic performance 2. Solid vascular tissue !25% of lesiony
of a preoperative sonographic adnexal mass scoring system 3. Solid vascular tissue 25-50% of lesion
4. Solid vascular tissue O50% of lesion
based on mass volume and amount of solid vascular tissue
in the pediatric and adolescent population. Volume Scorez
1. !100 mL
2. 100-250 mL
Materials and Methods
3. 250-500 mL
4. O500 mL
Patient Population
* Requirement: presence of spectral Doppler flow.
y
Minimum size of O3 mm with confirmation of flow with spectral Doppler to
This is a retrospective study of all female individuals 1- qualify.
z
18 years of age presenting with an adnexal mass to The Volume 5 length  height  width  0.523.

Hospital for Sick Children (Toronto, Ontario, Canada) be-


tween April 2011 and March 2016 and was conducted with included a variety of adnexal mass sizes and pathologies,
approval of our institutional Research Ethics Board. Patients which were separate from the study cohort. Subsequently,
who did not receive surgical management or preoperative the same 2 in-training pediatric radiology fellows sepa-
ultrasound that included spectral Doppler were excluded. rately analyzed all presenting ultrasounds in the study
The inclusion dates mirror a similar cohort used in previous cohort, again blinded to the pathologic results. All cases in
risk stratification studies from our institution,4 which al- the training cohort and discrepancies in the study cohort
lows for direct comparisons of diagnostic performance. A were reviewed with 2 staff pediatric radiologists (CZL and
separate representative training cohort was derived from OMN) to achieve group consensus agreement, for training
ultrasound examinations of surgically managed adnexal purposes and for final consensus interpretation,
masses in patients presenting between March 2016 and respectively.
March 2019.
Statistical Analysis
Ultrasound Technique

All analyses were carried out with SAS University Edition


All ultrasound studies were performed by dedicated pe-
(Base SAS, SAS Institute Inc, Cary, NC). Diagnostic perfor-
diatric sonographers with a transabdominal approach. All
mance was assessed using sensitivity, specificity, PPV, NPV,
examinations included gray scale, color Doppler, and spectral
positive likelihood ratio (LRþ), and negative likelihood ratio
Doppler performed on Samsung RS80 A (Samsung Medison
(LR), considering P ! .05 (2-tailed) as statistically signif-
Corp., Korea), Philips iU22 (Philips Ultrasound, USA), Toshiba
icant. Receiver operating characteristic (ROC) curves and
Aplio 500, or Toshiba Aplio XG (Toshiba Medical Systems
area-under-the-curve (AUC) values were also obtained,
Corp., Japan) ultrasound machines using a low-frequency
with optimum cut-off values determined by the Youden
convex-array transducer (1-7 MHz Samsung CA1-7A, 2-
index. Final pathologic diagnosis was used as the reference
5 MHz Philips C5-2, 2-6 MHz Toshiba PVT-375BT) and in
standard. Interobserver variability was assessed using k
some cases a high-frequency linear-array transducer (3-
statistics with quadratic weighting. The k value was inter-
12 MHz Samsung L3-12A, 3-12 MHz Philips L12-3, 7-14 MHz
preted according to Landis and Koch13 with 0.0-0.20 rep-
Toshiba PLT-1005BT). All ultrasound machines were repre-
resenting slight agreement, 0.21-0.40 fair agreement, 0.41-
sented in both the test and training cohorts.
0.6 moderate agreement, 0.61-0.80 good agreement, and
Scoring System: Volume and Solid Vascular Tissue Score 0.81-1.00 very good agreement.

All adnexal masses were assigned a sonographic volume Results


score (0-3) and solid vascular score (0-3) (Table 1). Thick-
ness of at least 3 mm with confirmation of flow via spectral In total, 169 patients with 179 masses with surgical
Doppler was required to qualify as solid vascular tissue (Fig management of adnexal masses were identified, with 10.6%
1). Therefore, thin septations with flow did not qualify. The of the lesions being malignant. The mean age of the study
volume and solid vascular scores were summed for each population was 13.0  3.4 years. 73.7% of the study popu-
case to create a combined Volume and Solid Vascular Tissue lation was postmenarchal. All pathologic diagnoses are lis-
Score (VSVTS) ranging from 0 to 6. All other ultrasound ted in Table 2.
features were not considered in this study. The distribution of pathologic entities per VSVTS is
depicted in Table 3. The distribution of pathologic entities
Ultrasound Analysis per volume score and solid vascular tissue score is available
in Supplemental Table 1.
Two in-training pediatric radiology fellows (LFR and EA) The sensitivity, specificity, PPV, NPV, LRþ, and LR for
who were blinded to pathologic results independently malignancy for each component of the scoring system is
analyzed a training cohort of 21 representative cases that shown in Table 4. A volume score of $2 showed a PPV of

Downloaded for Anonymous User (n/a) at Jawaharlal Institute of Postgraduate Medical Education and Research from ClinicalKey.in by
Elsevier on June 07, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.
s Roca et al. / J Pediatr Adolesc Gynecol 34 (2021) 377e382
L. Farra 379
web 4C=FPO

Fig. 1. Solid vascular tissue score examples on color Doppler (left) and corresponding spectral Doppler images (right). (A) Score of 0 for a cystic lesion with no internal flow. Note
that some flow is seen in the adjacent normal ovarian tissue (arrow). This was a mature teratoma. (B) Score of 1 for a cystic lesion with a hyperechoic papillary projection comprising
!25% of the lesion size and with some internal flow. This was a mature teratoma. (C) Score of 2 for a cystic lesion with a central solid component comprising 25-50% of the lesion
size and with internal flow. This was an immature teratoma. (D) Score of 3 for a mixed solid-cystic lesion with solid component comprising O50% of the lesion and with internal
flow. This was a juvenile granulosa cell tumor.

0.19 (95% CI 0.15-0.22), NPV of 0.98 (95% CI 0.92-0.99), LRþ Interrater reliability via weighted k-statistics showed
of 2.00 (95% CI 1.59-2.51), and LR of 0.19 (95% CI 0.05- very good agreement for the volume score, solid vascular
0.71). The presence of any solid vascular tissue defined by tissue score, and VSVTS with k values of 0.998 (95% CI
scores 1, 2, or 3 showed a PPV of 0.35 (95% CI 0.28-0.44), 0.995-1.002), 0.894 (95% CI 0.829-0.959), and 0.969 (95% CI
0.52 (95% CI 0.36-0.68), and 0.67 (95% CI 0.43-0.84), NPV of 0.950-0.988), respectively.
0.98 (95% CI 0.94-0.99), 0.96 (95% CI 0.92-0.97), and 0.95 Targeted review of the 4 cases misclassified as benign
(95% CI 0.91-0.96), LRþ of 4.65 (95% CI 3.27-6.61), 9.24 (95% using a VSVTS of 4 revealed 2 mixed germ cell tumors, 1
CI 4.75-17.99), and 16.95 (95% CI 6.47-44.37), and LReof 0.13 borderline tumor, and 1 juvenile granulosa cell tumor. The 2
(95% CI 0.04 -0.48), 0.40 (95% CI 0.22-0.71), and 0.49 (95% CI mixed germ cell tumors had a volume score of 3 and solid
0.30-0.79), respectively. A VSVTS of $4 showed a PPV of vascular tissue score of 0, showing apparent avascular
0.44 (95% CI 0.33-0.56), NPV of 0.97 (95% CI 0.94-0.99), LRþ heterogeneous solid tissue occupying up to 50% of the
of 6.77 (95% CI 4.18-10.97), and LReof 0.24 (95% CI 0.10- lesion. The borderline tumor similarly had a volume score of
0.57). The ROC AUCs for the volume score, solid vascular 3 and solid vascular tissue score of 0. It was a O20-cm
tissue score, and VSVTS were 0.734, 0.890, and 0.919 multicystic lesion with apparent avascular papillary pro-
respectively (Fig. 2). jections. The juvenile granulosa cell tumor was a predom-
inantly solid vascular mass with volume of 95.3 mL, which
classified as a volume score of 0 and solid vascular score
Table 2
of 3.
Pathology of Adnexal Masses (n 5 179)

Benign 160 (89.4%) Discussion


Mature teratoma 72 (40.2%)
Cystadenoma 50 (28.0%)
Paratubal cyst 20 (11.2%) In this study, we evaluate the diagnostic performance of
Hemorrhagic cyst 8 (4.4%) a sonographic volume and solid vascular tissue score for
Simple/follicular cyst 4 (2.2%)
preoperative risk stratification of adnexal masses in the
Benign sex cord stromal tumor 3 (1.7%)
Corpus luteum 2 (1.1%) pediatric and adolescent population. The major finding of
Ovarian edema 1 (0.5%) our study is that the addition of a solid vascular tissue score
Malignant 19 (10.6%)
to preoperative assessment shows incremental benefit to
Borderline tumor 4 (2.2%)
Immature teratoma 3 (1.7%) PPV and LR þ while maintaining reasonable NPV and
Mixed germ cell tumor 3 (1.7%) LRefor prediction of malignancy in pediatric and adolescent
Juvenile granulosa cell tumor 2 (1.1%)
adnexal masses.
Dysgerminoma 2 (1.1%)
Sertoli-Leydig tumor 2 (1.1%) Multiple ultrasound-based scoring systems for preoper-
Mucinous carcinoma 1 (0.5%) ative risk assessment of adnexal masses in the pediatric
Neuroendocrine tumor 1 (0.5%)
population have been proposed.2e5,7,9 Although they all
Yolk sac tumor 1 (0.5%)
achieve acceptable NPV, the PPV has been difficult to

Downloaded for Anonymous User (n/a) at Jawaharlal Institute of Postgraduate Medical Education and Research from ClinicalKey.in by
Elsevier on June 07, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.
380 s Roca et al. / J Pediatr Adolesc Gynecol 34 (2021) 377e382
L. Farra

Table 3 optimize, ranging from 13.0% to 37.1%. So far, only by


Distribution of Tumor Histology by VSVTS
including additional clinical information has PPV been able
VSVTS Benign Malignant to be improved. A scoring system by Loh et al7 combining
score
the presence of sex hormoneerelated symptoms with ul-
0 n 5 49 n50
trasound features similar to those in our study (size of solid
Mature teratoma 5 19
Cystadenoma 5 13 component and presence of vascular flow) was able to
Paratubal cyst 5 10 achieve an NPV of 98.5% and a PPV of 90.9%. An algorithm
Hemorrhagic cyst 5 4
developed by Stankovic et al5 that involved segregation of
Simple/follicular cyst 5 2
Corpus luteum 5 1 patients by presenting symptoms combined with morpho-
1 n 5 32 n50 logic ultrasound features achieved a NPV of 99% and PPV of
Mature teratoma 5 16
86%. However, we were not able to replicate this latter study
Cystadenoma 5 11
Hemorrhagic cyst 5 2 retrospectively in our own population.4 Nonetheless, the
Paratubal cyst 5 2 literature to date seems to imply that preoperative risk
Simple/follicular cyst 5 1
stratification based on ultrasound features alone has a
2 n 5 16 n50
Mature teratoma 5 6 limitation in specificity for malignancy, which could lead to
Cystadenoma 5 6 excessive oophorectomies for benign tumors.
Paratubal cyst 5 2
Part of the challenge in the pediatric and adolescent
Corpus luteum 5 1
Hemorrhagic cyst 5 1 population in this regard is the high proportion of germ
3 n 5 44 n54 cell tumors in premenarchal girls, the majority of which
Mature teratoma 5 19 Mixed germ cell tumor 5 2
are benign.14,15 Large benign mature cystic teratomas have
Cystadenoma 5 15 Borderline tumor 5 1
Paratubal cyst 5 6 Juvenile granulosa cell overlapping imaging appearances with malignant germ
Simple/follicular cyst 5 1 tumor 5 1 cell tumors, and can lead to suboptimal specificity and
Hemorrhagic cyst 5 1
PPV, particularly when attempting to apply algorithms
Ovarian edema 5 1
Benign sex cord stromal developed in adult populations to children. In our expe-
tumor 5 1 rience, these large teratomas have little to no detectable
4 n 5 14 n55
Mature teratoma 5 10 Borderline tumor 5 3
spectral Doppler flow within solid-appearing components
Cystadenoma 5 4 Immature teratoma 5 1 despite their large size and complexity. While studied in
Mixed germ cell tumor 5 1 adults, few data are available regarding the utility of
5 n52 n55
Mature teratoma 5 1 Dysgerminoma 5 1
assessing vascularity of adnexal masses in the pediatric
Benign sex cord stromal Juvenile granulosa cell population. Depoers et al2 recently applied the Interna-
tumor 5 1 tumor 5 1 tional Ovarian Tumor Analysis (IOTA) rules that included
Sertoli-Leydig tumor 5 1
Mucinous carcinoma 5 1
subjective assessments of color Doppler signal strength
Neuroendocrine tumor 5 1 into an algorithm, which apparently did not contribute to
6 n53 n55 risk analysis. Our sense, however, was that rather than the
Mature teratoma 5 1 Immature teratoma 5 2
Cystadenoma 5 1 Dysgerminoma 5 1
strength of color Doppler signal as validated in adults,
Benign sex cord stromal Yolk sac tumor 5 1 even small amounts of tissue with flow could portend
tumor 5 1 Sertoli-Leydig tumor 5 1 malignancy or higher-grade, given our unique population.
VSVTS, Volume and Solid Vascular Tissue Score. This is supported by the work by Loh et al,7 in which a
binary discriminator of presence of absence of vascular

Table 4
Statistical Analysis for Volume, Solid Vascular Tissue, and Total Score

Score Sensitivity [95% CI] Specificity [95% CI] PPV [95% CI] NPV [95% CI] LRþ [95% C] LRe [95% CI]

Volume score $0 1.00 [0.82-1.00] 0.00 [0.00-0.22] 0.10 [1.00-1.00] e [e] 1.00 [0.10-0.10] e [e]
$1 0.95 [0.74-1.00] 0.34 [0.26-0.41] 0.14 [0.12-0.16] 0.98 [0.89-0.99] 1.43 [1.23-1.67] 0.16 [0.02-1.06]
$2 0.89 [0.67-0.99] 0.55 [0.47-0.63] 0.19 [0.15-0.22] 0.98 [0.92-0.99] 2.00 [1.59-2.51] 0.19 [0.05-0.71]
3 0.68 [0.43-0.87] 0.67 [0.59-0.74] 0.20 [0.14-0.26] 0.95 [0.90-0.97] 2.10 [1.44-3.07] 0.47 [0.24-0.91]
Solid vascular tissue score $0 1.00 [0.82-1.00] 0.00 [0.00-0.23] 0.11 [0.10-0.10] e [e] 1.00 [1.00-1.00] e [e]
$1 0.89 [0.67-1.00] 0.81 [0.74-0.86] 0.35 [0.28-0.44] 0.98 [0.94-0.99] 4.65 [3.27-6.61] 0.13 [0.04-0.48]
$2 0.63 [0.38-0.84] 0.93 [0.88-0.96] 0.52 [0.36-0.68] 0.96 [0.92-0.97] 9.24 [4.75-17.99] 0.40 [0.22-0.71]
3 0.53 [0.29-0.75] 0.97 [0.93-0.99] 0.67 [0.43-0.84] 0.95 [0.91-0.96] 16.95 [6.47-44.37] 0.49 [0.30-0.79]
VSVTS $0 1.00 [0.82-1.00] 0.00 [0.00-0.22] 0.10 [0.10-0.10] e [e] 1.00 [1.00-1.00] e [e]
$1 1.00 [0.82-1.00] 0.31 [0.24-0.39] 0.15 [0.13-0.16] 1.00 [e] 1.46 [1.31-1.61] 0.00 [e]
$2 1.00 [0.82-1.00] 0.52 [0.43-0.59] 0.19 [0.17-0.22] 1.00 [e] 2.06 [1.76-2.42] 0.00 [e]
$3 1.00 [0.82-1.00] 0.61 [0.53-0.69] 0.23 [0.19-0.27] 1.00 [e] 2.59 [2.13-3.14] 0.00 [e]
$4 0.79 [0.54-0.93] 0.88 [0.82-0.93] 0.44 [0.33-0.56] 0.97 [0.94-0.99] 6.77 [4.18-10.97] 0.24 [0.10-0.57]
$5 0.53 [0.29-0.75] 0.97 [0.93-0.99] 0.67 [0.43-0.84] 0.95 [0.92-0.96] 17.16 [6.55-44.93] 0.49 [0.30-0.79]
6 0.26 [0.09-0.51] 0.98 [0.95-0.99] 0.63 [0.30-0.86] 0.92 [0.89-0.93] 14.30 [3.71-55.1] 0.75 [0.57-0.98]

CI, confidence interval; LRþ, positive likelihood ratio; LR, negative likelihood ratio; NPV, negative predictive value; PPV, positive predictive value; VSVTS, Volume and Solid
Vascular Tissue Score.

Downloaded for Anonymous User (n/a) at Jawaharlal Institute of Postgraduate Medical Education and Research from ClinicalKey.in by
Elsevier on June 07, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.
s Roca et al. / J Pediatr Adolesc Gynecol 34 (2021) 377e382
L. Farra 381
web 4C=FPO

Fig. 2. Receiver operating characteristic curves for the volume score (A), solid vascular tissue score (B), and total Volume and Solid Vascular Tissue Score (VSVTS) (C) with area under
the curve (AUC) provided. Cut-off value based on the Youden index (red “ 5 ” sign) for the volume score (A) is 2 (sensitivity 89%, specificity 55%), for the solid vascular tissue score
(B) is 1 (sensitivity 89%, specificity 81%), and for the total VSTVS (C) is 4 (sensitivity 79%, specificity 88%).

flow contributed to assessment. Therefore, we hypothe- performance can be operator dependent, and the demon-
sized that the degree of solid vascular tissue rather than stration of solid vascularized tissue by spectral Doppler may
the morphology itself or subjective strength of vascularity have been variable.
could help with PPV and LRþ.
The simplified sonographic scoring system tested in this Conclusion
work using only size and presence of solid vascular tissue
criteria demonstrates slightly higher PPV of 0.44 and A sonographic scoring system based on the volume and
reasonable NPV of 0.97 as compared to that of other presence of solid vascular tissue improved PPV for preop-
ultrasound-only scoring systems, including comparison erative risk stratification of adnexal masses in the pediatric
with more complicated algorithms.2e4,9 This further sup- and adolescent population compared to existing
ports the utility of incorporating vascularity into the eval- ultrasound-only approaches. Further prospective research
uation of adnexal masses. is needed to determine how best to incorporate compo-
Although we achieved our goal of improving PPV, it nents of such scoring systems into clinical management
was also important for us to look more closely at the 4 algorithms.
cases misclassified as benign when using a VSVTS of $4
as the sole criterion, as diagnostic tests are always a Acknowledgments
balance between sensitivity and specificity. These 4 cases
all had other features that made them suspicious for The authors would like to acknowledge the support from
malignancy, whether it was the 2 mixed germ cell tumors the Ontasian Imaging Lab (OIL).
and 1 borderline tumor that each contained a significant
proportion of heterogenous solid tissue despite apparent Supplementary Data
avascularity, or the juvenile granulosa cell tumor that
Supplementary data related to this article can be found at
contained clearly vascular neoplastic tissue but measured
https://doi.org/10.1016/j.jpag.2020.11.017.
just 5 mL beneath the cut-off to be classified as malig-
nant. Therefore, human judgment still seems to be
References
important.
Ultimately, our work supports future prospective work 1. Kirkham YA, Lacy JA, Kives S, et al: Characteristics and management of adnexal
incorporating presence and percentage of solid vascular masses in a Canadian pediatric and adolescent population. J Obstet Gynaecol
Can 2011; 33:935e43
tissue into more sophisticated algorithms, which may 2. Depoers C, Martin FA, Timoh KN, et al: A Preoperative scoring system for
further improve preoperative risk stratification, particularly adnexal mass in children and adolescents to preserve their future fertility. J
Pediatr Adolesc Gynecol 2019; 32:57e63
with inclusion of non-imaging clinical parameters. None- 3. Rogers EM, Cubides GC, Lacy J, et al: Preoperative risk stratification of adnexal
theless, although the use of structured preoperative algo- masses: can we predict the optimal surgical management? J Pediatr Adolesc
Gynecol 2014; 27:125e8
rithms has potential for establishing standardized starting 4. Goldberg HR, Kives S, Allen L, et al: Preoperative risk stratification of adnexal
points, for now a multidisciplinary discussion on a case-by- masses in the pediatric and adolescent population: evaluating the Decision
case basis with expert consensus likely will continue to be Tree System. J Pediatr Adolesc Gynecol 2019; 32:633e8
5. Stankovic ZB, Sedlecky K, Savi
c D, et al: Ovarian preservation from tumors and
required.3,13,16 torsions in girls: prospective diagnostic study. J Pediatr Adolesc Gynecol 2017;
The strength of our study is the sizeable group of surgi- 30:405e12
6. Ueland FR, DePriest PD, Pavlik EJ, et al: Preoperative differentiation of
cally managed patients using a similar cohort as previous malignant from benign ovarian tumors: the efficacy of morphology indexing
works from our institution, allowing for direct comparison and Doppler flow sonography. Gynecologic Oncology 2003; 91:46
7. Loh AHP, Li Ong C, Lam SL, et al: Pediatric risk of malignancy index for
with other approaches. Limitations relate to the retrospec- preoperative evaluation of childhood ovarian tumors. Pediatr Surg Int 2012;
tive review of ultrasound examinations, in which diagnostic 28:259e66

Downloaded for Anonymous User (n/a) at Jawaharlal Institute of Postgraduate Medical Education and Research from ClinicalKey.in by
Elsevier on June 07, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.
382 s Roca et al. / J Pediatr Adolesc Gynecol 34 (2021) 377e382
L. Farra

8. Madenci AL, Levine BS, Laufer MR, et al: Preoperative risk stratification of Ovarian-Adnexal Reporting and Data System Committee. Radiology 2020;
children with ovarian tumors. J Pediatr Surg 2016; 51:1507e12 294:168e85
9. Abbas PI, Elder SC, Mehollin-Ray AR, et al: Ovarian lesions volumes as a 13. Landis JR, Koch GG: An application of hierarchical kappa-type statistics in the
screening tool for malignancy in adolescent ovarian tumors. J Pediatr Surg assessment of majority agreement among multiple observers. Biometrics 1977;
2015; 50:1933e6 33:363e74
10. Papic JC, Finnell SM, Slaven JE, et al: Predictors of ovarian malignancy in 14. Hermans AJ, Kluivers KB, Janssen LM: Adnexal masses in children, adolescents
children: overcoming clinical barriers of ovarian preservation. J Pediatr Surg and women of reproductive age in the Netherlands: a nationwide
2014; 49:144e7 population-based cohort study. Gynecol Oncol 2016; 143:93e7
11. Timmerman D, Ameye L, Fischerova D, et al: Simple ultrasound rules to 15. Lam CZ, Chavhan GB: MRI of pediatric adnexal masses and mimics. Pediatr
distinguish between benign and malignant adnexal masses before surgery: Radiol 2018; 48:1291e306
prospective validation by IOTA group. BMJ 2010; 314:c6839 16. Lawrence AE, Gonzalez DO, Fallat ME, et al: Factors associated with
12. Andreotti RF, Timmerman D, Strachowski LM, et al: O-RADS US Risk management of pediatric ovarian neoplasms. Pediatrics 2019; 144:
Stratification and Management System: a consensus guideline from the ACR e20182537

Downloaded for Anonymous User (n/a) at Jawaharlal Institute of Postgraduate Medical Education and Research from ClinicalKey.in by
Elsevier on June 07, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.

You might also like